Name Address/P.O. Box Postal Code/City Country Contact Person Telephone Fax Email Website Social Media Number of Employees Founded (year) Areas of Activity
Annual Turnover External Collaborations Request for Further Collaborations
›
› › › › › › › ›
› › ›
›
OPIS s.r.l. Via Matteotti 10 20832 Desio Italy Giovanni Trolese +39-0362-633-1 +39-0362-633-633 office@opiseurope.com www.opiseurope.com www.clinical.net
I ca. 240 1998 Premium support for clinical drug and device development
›
€ 30 m
›
Pharma
›
| Pharma | Biotech | Medical device | Food supplements
Our organisation OPIS is a Global clinical CRO providing premium clinical trial management for multi-country trials. In addition to phase I-IV drug-related trials, OPIS also manages preand post-marketing clinical investigations for medical and diagnostic devices, as well as nutraceutical/food supplement studies. Founded in 1998, OPIS is a premium Global CRO, with roughly 300 employees. The company operates from its Italian headquarters and twelve other offices located around the world ( Spain, France, Germany, UK, Belgium, Sweden, Poland, Switzerland, The Netherlands, United States, Taiwan, and Australia).
Our expertise In 23 years of combining medical, regulatory, statistical, and technological expertise, OPIS has assisted a huge number of different clients with interventional and observational trials. Full-service projects in a wide range of therapeutic areas include various rare disease indications as well as pediatric studies. Currently, over 40% of trials managed by OPIS are oncology or onco-hematology trials. Other major therapeutic areas include ophthalmology, neurology, and cardiology. OPIS has established a solid collaboration with numerous international sponsors on multi-country trials.
Our mission We draw on our know-how, experience, professionalism, and ethical values to assist our partners in developing drugs in compliance with laws and regulations, while achieving the objective at a quick paste. Our strength lies in the passion for what we do and in the quality with which we deliver. We believe that clinical studies, particularly those incorporating scientific and methodological innovation, can significantly contribute to medical progress and to better quality of life.
